Shirish Gadgeel, MBBS

Biography

Dr. Gadgeel is Vice-Chair of Clinical Research and Professor in the Department of Hematology and Oncology at Winship Cancer Institute of Emory University in Atlanta. Dr. Gadgeel is a medical oncologist and has focused on lung cancer research in general and drug development in lung cancer, in particular.Dr. Gadgeel has conducted and participated in many lung cancer specific trials and in phase I trials, including investigator initiated trials based on laboratory research.He was co-author on major phase III trials ALEX and Keynote 189 which changed the standard of care. Dr. Gadgeel also engaged in many epidemiologic studies in the field of lung cancer, publishing on features of lung cancer in African Americans and in young patients. Dr. Gadgeel was co-leader of the Thoracic Oncology Research Program and the Mary Lou Kennedy Research Professor in Thoracic Oncology at the University of Michigan and he was Chief of the Division of Hematology/Oncology at Henry Ford Cancer before joining Emory University. Dr. Gadgeel is a member of the Editorial Board of Clinical Lung Cancer and a reviewer for many journals including Journal of Clinical Oncology, Lancet Oncology, Annals of Oncology and Journal of Thoracic Oncology. Dr.Gadgeel also served as faculty for the annual meeting of the American Society of Clinical Oncology (ASCO) and as a member of the Education Committee of ASCO and currently serve on ASCO Guidelines Panel. Dr. Gadgeel is a member of the Career Development Committee of the International Association of Study of Lung Cancer (IASLC). Dr. Gadgeel achieved the designation of Fellow of the American Society of Clinical Oncology (FASCO) in 2025. I was awarded by the NCI the Cancer Clinical Investigator Team Leadership Award in 2012.